Industry and News Hyoscine-N-Butyl Bromide Market | Page 2

bromide). In the parasympathetic nervous system, Hyoscine N-butyl bromide acts by interfering
with the transmission of nerve impulses by acetylcholine. These are the sugar-coated tablets that
contain 10 mg of the main active ingredient.
On the other hand, these medicines are not suitable for patients with glaucoma, myasthenia gravis,
or megacolon. They are also not suitable for the patients with known hypersensitivity to hyoscine-N-
butyl bromide or the other components of the product.
Hyoscine-N-Butyl Bromide Market is segmented based on drug class, application, and region. Drug
classes such as Antispasmodic and Anticholinergic classify Hyoscine-N-Butyl Bromide Market.
Applications into Injection, Oral, and others classify Hyoscine-N-Butyl Bromide Market. Hyoscine-N-
Butyl Bromide Market is segmented, geographically into Americas (North America, South America),
Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.
The key players of Hyoscine-N-Butyl Bromide Market are Alkaloids, Boehringer-Ingelheim, Alchem
International, and Linnea. These players are concentrating on inorganic growth to sustain
themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the
need of the hour.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/hyoscine-n-butyl-bromide-market
Market Segment:
Geographically, this report is segmented into several key Regions, with production, consumption,
revenue (million USD), market share and growth rate of Hyoscine-N-Butyl Bromide in these
regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan